HR 4116 · 115th Congress · Health

Transparent Drug Pricing Act of 2017

Introduced 2017-10-25· Sponsored by Rep. Doggett, Lloyd [D-TX-35]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2017-10-27)

Plain Language Summary

[AI summary unavailable — showing source text] Transparent Drug Pricing Act of 2017 This bill requires drug manufacturers to report specified financial and sales information, including drug pricing, tax credit, and patent information; violations are subject to civil penalties.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (20)

20 Democrats
Rep. Cummings, Elijah E. [D-MD-7]MD
Rep. DeLauro, Rosa L. [D-CT-3]CT
Rep. Ellison, Keith [D-MN-5]MN
Rep. Pocan, Mark [D-WI-2]WI
Rep. Grijalva, Raúl M. [D-AZ-3]AZ
Rep. Cicilline, David N. [D-RI-1]RI
Rep. Cohen, Steve [D-TN-9]TN
Rep. Conyers, John, Jr. [D-MI-13]MI
Rep. Higgins, Brian [D-NY-26]NY
Rep. Kaptur, Marcy [D-OH-9]OH
Rep. Nadler, Jerrold [D-NY-10]NY
Rep. Raskin, Jamie [D-MD-8]MD
Rep. Jayapal, Pramila [D-WA-7]WA
Rep. Welch, Peter [D-VT-At Large]VT
Rep. Chu, Judy [D-CA-27]CA
Rep. Johnson, Henry C. "Hank," Jr. [D-GA-4]GA
Rep. Blumenauer, Earl [D-OR-3]OR
Rep. Pingree, Chellie [D-ME-1]ME
Del. Norton, Eleanor Holmes [D-DC-At Large]DC
Rep. Khanna, Ro [D-CA-17]CA